Telehealth’s Impact on PrEP Initiation: Insights on Adherence and Engagement Challenges
A recent study, “Effectiveness of PrEPTECH,” conducted in California and Florida, evaluated a telehealth intervention aimed at encouraging young men who have sex with men and transgender women to begin oral pre-exposure prophylaxis (PrEP). This research provides critical insights into the initiation and sustained use of PrEP through virtual platforms, addressing both the successes and limitations of telehealth in facilitating long-term health outcomes.
Key Points:
- Study Design: The study, titled “Effectiveness of PrEPTECH,” was a randomized controlled trial that evaluated the impact of a telehealth platform, PrEPTECH, versus traditional online resources in starting PrEP among young men who have sex with men and transgender women.
- Participant Demographics: Participants included 229 individuals from California and Florida, with a mean age of 24 years; 23% were white.
- Intervention Details: PrEPTECH provided a complete telehealth service, including home testing kits for HIV/STIs, online education, and a free 30-day supply of PrEP, mailed directly to participants.
- Initial Uptake: The intervention significantly increased the odds of participants starting PrEP (odds ratio 6.63 at 90 days) compared to those who received only online resources.
- Long-term Adherence: At the 180-day follow-up, there were no significant differences in adherence to PrEP, recent PrEP use, or unprotected sexual acts between the intervention and control groups.
- Challenges and Barriers: About 27% of participants in the intervention arm never accessed their PrEP prescription, indicating potential barriers to telehealth engagement.
- Study Limitations: Limitations included a lack of adolescent participants, geographic restrictions, reliance on self-reported data, and no evaluation of the influence of free services on long-term PrEP usage.
- Implications for Practice: The study suggests that, although telehealth can initiate PrEP use, additional support from community health partners may be necessary to maintain adherence and address personal and structural barriers.
![](https://hcn.health/wp-content/uploads/2023/09/did-you-know.png)
According to the CDC, while PrEP can reduce the risk of HIV infection by up to 99% when taken consistently, less than 20% of the 1.2 million Americans who could benefit from PrEP were prescribed it in 2019.
More on HIV